Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Invokana Diabetic Ketoacidosis Risk Seen Among Type 1 Diabetics in Study November 5, 2015 Irvin Jackson Add Your Comments Following recent FDA warnings that suggest type 2 diabetics may face an increased risk of acid build up in the blood from Invokana side effects, the findings of a new study suggest that individuals with type 1 diabetes may also face a significantly increased risk of the diabetic acidosis following use of the new-generation treatment. According to findings of a study published last month in the medical journal Diabetes Care, researchers from California and Johnson & Johnson’s Janssen subsidiary indicate that while Invokana may help some type 1 diabetics with glycemic control, it also increases the risk of ketoacidosis, which is a condition caused by high acid levels in the blood that can result in severe health complications and the need for emergency hospital treatment. Invokana (canagliflozin) is part of a new class of drugs that is only approved for treatment of type 2 diabetes, working in a unique way by inhibiting some kidney functions to increase glucose production and lower blood glucose levels. Learn More About Invokana Lawsuits Side effects of Invokana have been linked to reports of ketoacidosis and kidney failure. Lawsuits are being reviewed by lawyers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Invokana Lawsuits Side effects of Invokana have been linked to reports of ketoacidosis and kidney failure. Lawsuits are being reviewed by lawyers. Learn More SEE IF YOU QUALIFY FOR COMPENSATION While type 2 diabetes is an acquired and curable condition, type 1 diabetics are usually born with the condition and it usually persists for life. While Invokana is commonly prescribed “off-label” for type 1 diabetes, the drug maker has been attempting to obtain expanded approval for the medication beyond type 2 diabetics to open up a new and expanded market. In this latest study, researchers conducted an 18-week, double-blind study of 351 patients taking insuline for type 1 diabetes and gave them either a placebo or a 100 mg or 300 mg regimen of Invokana. The study looked for changes in levels of glycated haemoglobin (HbA1c), body weight and other adverse events (AEs). According to the findings, patients taking Invokana saw a 0.4% drop in HbA1c, compared to the placebo group. Most did not gain weight and some lost weight. However, those taking the 100 mg dose of Invokana had a 5.4% rate of ketone-related adverse events, including ketoacidosis. Those given the larger 300 mg dose had a 9.4% rate of such events. There were none among the group given the placebo. The findings appear to provide additional support for recent concerns about the link between Invokana and diabetic ketoacidosis (DKA), which can result in symptoms like difficulty breathing, nausea, vomiting, abdominal pain, confusion, fatigue or sleepiness, often requiring urgent medical treatment and potentially resulting in severe health consequences. Invokana Ketoacidosis Concerns Invokana (canagliflozin) was introduced in March 2013, as the first member of a new class of diabetes drugs known as sodium-glucose-cotransporter-2 (SGLT-2) inhibitors. Farxiga (dapagliflozin) was the second member, introduced in 2014, followed by other similar drugs like Jardiance, Invokamet, Xigduo XR and Glyxambi. During the short time the new-generation of diabetes drugs have been on the market, they have rapidly grown to become big-sellers, largely driven by direct-to-consumer advertisements where the drug makers encouraged patients to seek out the new diabetes treatments. This study is the second phase of clinical trials by Janssen, the manufacturer, to show that the drug can be used for treatment of type 1 diabetes, which impacts an estimated 1.25 million American children and adults. While doctors are allowed to prescribe a drug for any reason they see fit, it is illegal for drug manufacturers to promote their medications for uses not approved by the FDA until they have provided sufficient evidence to establish that it is safe and effective for a new category of treatment. Concerns over the ads for SGLT-2 inhibitors have taken on a new sense of urgency this summer, after the FDA issued a drug safety communication about a potential increased risk of ketoacidosis with Invokana and other related drugs. During the first 15 months that Invokana was on the market, the FDA indicated that more than 20 adverse event reports were received involving individuals using an SGLT2 inhibitor who required emergency room treatment or hospitalization due to diabetic ketoacidosis, ketosis, acidosis or other related conditions that involve a build up of acid in the blood, known as ketones. This can result in symptoms like difficulty breathing, nausea, vomiting, abdominal pain, confusion, fatigue or sleepiness, often requiring urgent medical treatment and potentially resulting in severe health consequences. Invokana Lawsuits Over Failure to Warn Amid the recent FDA warnings, many consumers are now pursuing an Invokana lawsuit, alleging that the drug maker failed to adequately warn about the potential side effects for diabetics. Given the detectable and preventable nature of diabetic ketoacidosis from Invokana, if it can be established that the drug makers withheld information about the risk from consumers and the medical community, financial compensation may be available for individuals who have suffered a DKA injury. Potential failure to warn lawsuits are also being investigated by some lawyers for individuals who have suffered kidney failure from Invokana side effects, as reports suggest that the mechanism of action for the diabetes drug may damage the kidneys. In May 2015, a report released by the Institute for Safe Medication Practices (ISMP) evaluated adverse event reports submitted to the FDA during the first year Invokana was on teh market, identifying several safety signals involving kidney toxicity. The group raised questions about whether the potential Invokana risks may actually outweigh the benefits. In addition to cases involving use of Invokana, potential Invokamet lawsuits, Farxiga lawsuits, Xigduo XR lawsuits, Jardiance lawsuits and Glyxambi lawsuits are also being reviewed by product liability lawyers throughout the U.S. Tags: Diabetes, Diabetes Drug, Diabetic Ketoacidosis, Invokana, Johnson & Johnson More Invokana Lawsuit Stories Invokana, Farxiga, and Similar Diabetes Drugs Effective, But Carry Genital Infection Risk: Study April 19, 2022 Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga January 13, 2021 Study Finds No Link Between Bone Fractures And Invokana, Similar Diabetes Drugs September 22, 2020 1 Comments Robert May 20, 2017 Invokana and dka go hand in hand, regardless of type one or type 2 diabetes. If you come down with dka, a type one diabetic should have the same rights as a type 2 diabetic. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Invokana, Farxiga, and Similar Diabetes Drugs Effective, But Carry Genital Infection Risk: Study April 19, 2022
Necrotizing Fasciitis Lawsuit Filed Over Flesh-Eating Genital Infection Caused By Diabetes Drug Farxiga January 13, 2021
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)